Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches

People with coronavirus disease (COVID-19) might have several risk factors for delirium, which could in turn notably worsen the prognosis. Although pharmacological approaches for delirium are debated, haloperidol and other first-generation antipsychotics are frequently employed, particularly for hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostuzzi, Giovanni, Gastaldon, Chiara, Papola, Davide, Fagiolini, Andrea, Dursun, Serdar, Taylor, David, Correll, Christoph U., Barbui, Corrado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372613/
https://www.ncbi.nlm.nih.gov/pubmed/32733668
http://dx.doi.org/10.1177/2045125320942703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372613/
https://www.ncbi.nlm.nih.gov/pubmed/32733668
http://dx.doi.org/10.1177/2045125320942703

Ejemplares similares